News for Healthier Living

SPRED2 loss drives liver cancer stemness via p53/miR-506-3p/KLF4

Researchers have identified a new tumor-suppressive circuit that controls stem-like behavior in hepatocellular carcinoma (HCC). The work shows that Sprouty-related, EVH1 domain-containing protein 2 (SPRED2) binds the tumor suppressor p53, enters the nucleus, and activates transcription of the microRNA miR-506-3p. In turn, miR-506-3p directly targets KLF4 messenger RNA, lowering KLF4 protein and reducing cancer stem cell (CSC) traits, including sphere formation, colony growth, invasion, and aldehyde dehydrogenase (ALDH) activity. The study defines a SPRED2/p53/miR-506-3p/KLF4 axis and suggests that restoring this pathway could help suppress HCC progression, recurrence, and treatment resistance.

October 8, 2026


October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026